Avanos Medical, Inc. – NYSE:AVNS
Avanos Medical stock price today
$11.43
-4.49
-28.2%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 3 hours
Avanos Medical stock price monthly change
-24.48%
month
Avanos Medical stock price quarterly change
-24.48%
quarter
Avanos Medical stock price yearly change
-30.05%
year
Avanos Medical key metrics
Market Cap | 736.23M |
Enterprise value | 1.55B |
P/E | 28 |
EV/Sales | 1.90 |
EV/EBITDA | 12.77 |
Price/Sales | 1.71 |
Price/Book | 1.08 |
PEG ratio | 0.03 |
EPS | -1.32 |
Revenue | 680.1M |
EBITDA | 75.5M |
Income | -62.2M |
Revenue Q/Q | -13.35% |
Revenue Y/Y | -16.48% |
Profit margin | 6.07% |
Oper. margin | 8.91% |
Gross margin | 54.77% |
EBIT margin | 8.91% |
EBITDA margin | 11.1% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAvanos Medical stock price history
Avanos Medical stock forecast
Avanos Medical financial statements
Average Price Target
$20
Potential upside: 74.97%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 169.4M | -68.1M | -40.2% |
|---|---|---|---|
| Sep 2023 | 171.3M | -3.7M | -2.16% |
| Dec 2023 | 173.3M | 10.5M | 6.06% |
| Mar 2024 | 166.1M | -900K | -0.54% |
| Jun 2023 | 1666700000 | 431.9M | 25.91% |
|---|---|---|---|
| Sep 2023 | 1724900000 | 502.8M | 29.15% |
| Dec 2023 | 1692400000 | 456.1M | 26.95% |
| Mar 2024 | 1661300000 | 433.4M | 26.09% |
| Jun 2023 | -2.6M | -6.5M | -4.1M |
|---|---|---|---|
| Sep 2023 | 29.1M | -48.9M | 46.7M |
| Dec 2023 | 12.7M | 81M | -114.7M |
| Mar 2024 | -8M | -2M | -700K |
Avanos Medical alternative data
| Aug 2023 | 4,044 |
|---|---|
| Sep 2023 | 4,044 |
| Oct 2023 | 4,044 |
| Nov 2023 | 4,044 |
| Dec 2023 | 4,044 |
| Jan 2024 | 4,044 |
| Feb 2024 | 4,044 |
| Mar 2024 | 3,771 |
| Apr 2024 | 3,771 |
| May 2024 | 3,771 |
| Jun 2024 | 3,771 |
| Jul 2024 | 3,771 |
Avanos Medical other data
59.13%
-33.02%
of AVNS is owned by hedge funds
204
-65
27.97M
-15.34M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 500 | 8000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | GREINER MICHAEL officer: SVP - Ch.. | Common Stock | 4,219 | N/A | N/A | ||
Option | HOLBROOK KERR officer: SVP, Chief Commercial .. | Common Stock | 2,531 | N/A | N/A | ||
Option | WOODY JOSEPH FRALIN director, officer.. | Common Stock | 15,821 | N/A | N/A | ||
Sale | GREINER MICHAEL officer: SVP - Ch.. | Common Stock | 3,800 | $19.11 | $72,618 | ||
Sale | GREINER MICHAEL officer: SVP - Ch.. | Common Stock | 714 | $19.12 | $13,652 | ||
Sale | GREINER MICHAEL officer: SVP - Ch.. | Common Stock | 2,231 | $19.13 | $42,679 | ||
Sale | GREINER MICHAEL officer: SVP - Ch.. | Common Stock | 337 | $19.14 | $6,450 | ||
Sale | GREINER MICHAEL officer: SVP - Ch.. | Common Stock | 808 | $19.15 | $15,473 | ||
Sale | GREINER MICHAEL officer: SVP - Ch.. | Common Stock | 110 | $19.16 | $2,108 | ||
Purchase | SHIMER JULIE ANN director | Common Stock | 500 | $19.85 | $9,925 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 20 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 4 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Avanos Medical stock today?
One share of Avanos Medical stock can currently be purchased for approximately $11.43.
-
When is Avanos Medical's next earnings date?
Unfortunately, Avanos Medical's (AVNS) next earnings date is currently unknown.
-
Does Avanos Medical pay dividends?
No, Avanos Medical does not pay dividends.
-
How much money does Avanos Medical make?
Avanos Medical has a market capitalization of 736.23M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 17.89% to 673.3M US dollars.
-
What is Avanos Medical's stock symbol?
Avanos Medical, Inc. is traded on the NYSE under the ticker symbol "AVNS".
-
What is Avanos Medical's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Avanos Medical?
Shares of Avanos Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Avanos Medical's key executives?
Avanos Medical's management team includes the following people:
- Mr. Joseph F. Woody Chief Executive Officer & Director(age: 59, pay: $2,470,000)
- Mr. Michael C. Greiner Senior Vice President, Chief Financial Officer & Principal Accounting Officer(age: 52, pay: $1,310,000)
- Mr. David Edward Ball Senior Vice President of Global Supply Chain & Procurement(age: 66, pay: $697,000)
- Mr. Arjun Ranjan Sarker Senior Vice President of International(age: 59, pay: $680,980)
- Mr. William David Haydon Senior Vice President & GM of Pain Management(age: 58, pay: $337,360)
-
How many employees does Avanos Medical have?
As Jul 2024, Avanos Medical employs 3,771 workers.
-
When Avanos Medical went public?
Avanos Medical, Inc. is publicly traded company for more then 10 years since IPO on 21 Oct 2014.
-
What is Avanos Medical's official website?
The official website for Avanos Medical is avanos.com.
-
Where are Avanos Medical's headquarters?
Avanos Medical is headquartered at 5405 Windward Parkway, Alpharetta, GA.
-
How can i contact Avanos Medical?
Avanos Medical's mailing address is 5405 Windward Parkway, Alpharetta, GA and company can be reached via phone at +84 44282667.
-
What is Avanos Medical stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Avanos Medical in the last 12 months, the avarage price target is $20. The average price target represents a 74.97% change from the last price of $11.43.
Avanos Medical company profile:
Avanos Medical, Inc.
avanos.comExchange:
NYSE
Full time employees:
3,771
Industry:
Medical - Devices
Sector:
Healthcare
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
5405 Windward Parkway
Alpharetta, GA 30004
Alpharetta, GA 30004
CIK: 0001606498
ISIN: US05350V1061
CUSIP: 05350V106
